A phase II study of capecitabine, oxaliplatin and selenomethionine and radiation therapy in patients with stage II and III rectal adenocarcinoma.
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Selenomethionine (Primary) ; Capecitabine; Oxaliplatin
- Indications Colorectal cancer
- Focus Therapeutic Use
Most Recent Events
- 17 Nov 2017 Biomarkers information updated
- 17 Dec 2009 Status changed from recruiting to discontinued as reported by ClinicalTrials.gov.
- 26 Oct 2008 Actual start date changed from Feb 2008 to Mar 2008 as reported by ClinicalTrials.gov.